| Dr Stuart A Yablon, MD | |
|
235 Wealthy St Se, Grand Rapids, MI 49503-5247 | |
| (616) 840-8005 | |
| (616) 840-9642 |
| Full Name | Dr Stuart A Yablon |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 37 Years |
| Location | 235 Wealthy St Se, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265477459 | NPI | - | NPPES |
| 00117314 | Medicaid | MS | |
| 8BZ365 | Other | TX | BCBSTX |
| 134926809 | Medicaid | TX |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spectrum Health | Grand rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mary Free Bed Rehabilitation Hospital | 4587576541 | 109 |
News Archive
Broad-spectrum antibiotics, which are active against a whole range of bacterial pathogens, have been on the market for a long time. Comparably versatile drugs to treat viral diseases, on the other hand, have remained elusive. Using a new approach, research teams led by Dr. Albrecht von Brunn of LMU Munich and Professor Christian Drosten from the University of Bonn have identified a compound that inhibits the replication of several different viruses, including the highly aggressive SARS virus that is responsible for severe acute respiratory syndrome.
Ecologists at the University of Georgia are leading a global effort to predict where new infectious diseases are likely to emerge. In a paper published in Ecology Letters, they describe how macroecology—the study of ecological patterns and processes across broad scales of time and space—can provide valuable insights about disease.
Acura Pharmaceuticals, Inc. today reported a second quarter 2010 net loss of $3.2 million or $0.07 per share compared to net loss of $6.5 million, or $0.14 per share for the second quarter of 2009. For the six months ended June 30, 2010, the Company reported a net loss of $7.2 million, or $0.15 per share compared to net loss of $7.8 million, or $0.17 per share for the same period in 2009. At July 29, 2010 we had cash and cash equivalents of approximately $26.5 million with no term indebtedness.
Mutations on a single gene, the huntingtin gene, are the cause of Huntington's disease. They lead to an incorrect form of the correspondent protein.
A new study shows how a large-scale wave of increased OC symptoms affected public behavior, such as seeking information about the pandemic.
› Verified 3 days ago
| Entity Name | Mary Free Bed Rehabilitation Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730133463 PECOS PAC ID: 4587576541 Enrollment ID: O20040116000604 |
News Archive
Broad-spectrum antibiotics, which are active against a whole range of bacterial pathogens, have been on the market for a long time. Comparably versatile drugs to treat viral diseases, on the other hand, have remained elusive. Using a new approach, research teams led by Dr. Albrecht von Brunn of LMU Munich and Professor Christian Drosten from the University of Bonn have identified a compound that inhibits the replication of several different viruses, including the highly aggressive SARS virus that is responsible for severe acute respiratory syndrome.
Ecologists at the University of Georgia are leading a global effort to predict where new infectious diseases are likely to emerge. In a paper published in Ecology Letters, they describe how macroecology—the study of ecological patterns and processes across broad scales of time and space—can provide valuable insights about disease.
Acura Pharmaceuticals, Inc. today reported a second quarter 2010 net loss of $3.2 million or $0.07 per share compared to net loss of $6.5 million, or $0.14 per share for the second quarter of 2009. For the six months ended June 30, 2010, the Company reported a net loss of $7.2 million, or $0.15 per share compared to net loss of $7.8 million, or $0.17 per share for the same period in 2009. At July 29, 2010 we had cash and cash equivalents of approximately $26.5 million with no term indebtedness.
Mutations on a single gene, the huntingtin gene, are the cause of Huntington's disease. They lead to an incorrect form of the correspondent protein.
A new study shows how a large-scale wave of increased OC symptoms affected public behavior, such as seeking information about the pandemic.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stuart A Yablon, MD 909 N Washington Ave, Dallas, TX 75246-1520 Ph: (214) 820-9391 | Dr Stuart A Yablon, MD 235 Wealthy St Se, Grand Rapids, MI 49503-5247 Ph: (616) 840-8005 |
News Archive
Broad-spectrum antibiotics, which are active against a whole range of bacterial pathogens, have been on the market for a long time. Comparably versatile drugs to treat viral diseases, on the other hand, have remained elusive. Using a new approach, research teams led by Dr. Albrecht von Brunn of LMU Munich and Professor Christian Drosten from the University of Bonn have identified a compound that inhibits the replication of several different viruses, including the highly aggressive SARS virus that is responsible for severe acute respiratory syndrome.
Ecologists at the University of Georgia are leading a global effort to predict where new infectious diseases are likely to emerge. In a paper published in Ecology Letters, they describe how macroecology—the study of ecological patterns and processes across broad scales of time and space—can provide valuable insights about disease.
Acura Pharmaceuticals, Inc. today reported a second quarter 2010 net loss of $3.2 million or $0.07 per share compared to net loss of $6.5 million, or $0.14 per share for the second quarter of 2009. For the six months ended June 30, 2010, the Company reported a net loss of $7.2 million, or $0.15 per share compared to net loss of $7.8 million, or $0.17 per share for the same period in 2009. At July 29, 2010 we had cash and cash equivalents of approximately $26.5 million with no term indebtedness.
Mutations on a single gene, the huntingtin gene, are the cause of Huntington's disease. They lead to an incorrect form of the correspondent protein.
A new study shows how a large-scale wave of increased OC symptoms affected public behavior, such as seeking information about the pandemic.
› Verified 3 days ago
Dr. Aashish A Deshpande, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 221 Michigan St Ne Ste 400, Grand Rapids, MI 49503 Phone: 616-486-9600 | |
Dr. Jacob H Reisner, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4100 Lake Dr Se Ste 300, Grand Rapids, MI 49546 Phone: 616-267-8860 | |
Jina Libby, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 200 Jefferson Ave Se Bldg Ste 305, Grand Rapids, MI 49503 Phone: 616-685-6867 | |
Andrea S Kuldanek, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 235 Wealthy St Se, Grand Rapids, MI 49503 Phone: 616-840-8005 Fax: 616-840-9642 | |
Christopher Rizik, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 235 Wealthy St Se, Grand Rapids, MI 49503 Phone: 616-840-8000 | |
Dr. Eric J Egeler, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Jason Toma, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2320 E Beltline Ave Se, Grand Rapids, MI 49546 Phone: 616-831-8666 |